72237-0101 XPOVIO - CanMED: NDC

Product NDC:

72237-0101

Brand Name:

XPOVIO

Generic Name:

Selinexor

Dosage Form Name:

TABLET, FILM COATED

Administration Route:

Oral

Substances:

Name: SELINEXOR

Strength: 20.0

Unit: mg/1

Packages:

Code: 72237-0101-01

Description: 4 BLISTER PACK in 1 CARTON (72237-101-01) / 3 TABLET, FILM COATED in 1 BLISTER PACK (72237-101-11)

Effective Date: July 10, 2019

Discontinued:

Code: 72237-0101-02

Description: 4 BLISTER PACK in 1 CARTON (72237-101-02) / 4 TABLET, FILM COATED in 1 BLISTER PACK (72237-101-12)

Effective Date: July 10, 2019

Discontinued:

Code: 72237-0101-03

Description: 4 BLISTER PACK in 1 CARTON (72237-101-03) / 6 TABLET, FILM COATED in 1 BLISTER PACK (72237-101-13)

Effective Date: June 22, 2020

Discontinued:

Code: 72237-0101-04

Description: 4 BLISTER PACK in 1 CARTON (72237-101-04) / 8 TABLET, FILM COATED in 1 BLISTER PACK (72237-101-14)

Effective Date: July 10, 2019

Discontinued:

Code: 72237-0101-05

Description: 4 BLISTER PACK in 1 CARTON (72237-101-05) / 5 TABLET, FILM COATED in 1 BLISTER PACK (72237-101-15)

Effective Date: July 10, 2019

Discontinued:

Code: 72237-0101-06

Description: 4 BLISTER PACK in 1 CARTON (72237-101-06) / 4 TABLET, FILM COATED in 1 BLISTER PACK (72237-101-16)

Effective Date: June 22, 2020

Discontinued:

Code: 72237-0101-07

Description: 4 BLISTER PACK in 1 CARTON (72237-101-07) / 2 TABLET, FILM COATED in 1 BLISTER PACK (72237-101-17)

Effective Date: June 22, 2020

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Enzyme Inhibitor

Minor Class:

XPO1

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox

CanMED: NDC